期刊文献+

益生菌联合标准三联疗法根除幽门螺杆菌的荟萃分析 被引量:32

Effect of Probiotics Supplementation on Standard Triple Therapy for Helicobacter pylori Eradication:A Systematic Review
下载PDF
导出
摘要 背景:标准三联疗法根除幽门螺杆菌(H.pylori)的根除率常低于80%,且胃肠道不良反应较明显。目的:系统性评价益生菌联合标准三联疗法能否提高H.pylori根除率,减少根除过程中的不良反应。方法:从常用电子数据库检索标准三联疗法联合与未联合益生菌根除H.pylori的随机临床试验,荟萃分析各项研究的根除率和不良反应发生率的合并OR值;行亚组分析和敏感性分析;以漏斗图检测发表偏倚。结果:共11项随机临床试验(1335例)符合纳入标准。三联疗法联合与未联合益生菌按意向治疗(ITT)分析的H.pylori根除率分别为81.8%(95%CI:80.9%~87.5%)和72.4%(95%CI:71.1%~79.3%),合并OR值为1.82(95%CI:1.31~2.51);总不良反应发生率分别为24.6%(95%CI:20.4%~29.2%)和38.7%(95%CI:32.4%~43.8%),合并OR值为0.44(95%CI:0.30~0.66)。结论:联合益生菌可有效提高标准三联疗法的H.pylori根除率,降低根除过程中的不良反应发生率。 It has become clear that the success rate of standard triple therapy for Helicobacter pylori (H. pylori) eradication are now frequently below 80%, furthermore, gastrointestinal side-effects are among the major pitfalls in such regimens. Aims: To systematically evaluate the effect of supplement with probiotics to standard triple therapy on the eradication rate and side-effects of anti-H, pylori treatment. Methods: Standardized searches of frequently used electronic databases for publications relevant to the topic areas were performed. According to the inclusion criteria, all randomized clinical trials comparing probiotics supplementation to placebo or without such treatment during anti-H, pylori regimens were included. The outcome measure examined was the summary odds ratio (OR) of improving H. pylori eradication rate and reducing side-effects. Sub-analysis and sensitivity analysis were also performed. The publication bias was tested by funnel plot. Results: Eleven randomized clinical trials including 1335 cases were identified. Pooled H. pylori eradication rate was 81.8% (95% CI: 80.9%-87.5%) and 72.4% (95% CI:71.1%-79.3%) for patients with or without probiotics, respectively, at intention-to-treat (ITT) analysis, the summary OR was 1.82 (95% CI: 1.31-2.51); the occurrence of total side-effects was 24.6% (95% CI: 20.4%-29.2%) and 38.7% (95% CI: 32.4%-43.8%) for groups with or without probiotics, respectively, the summary OR was 0.44 (95% CI: 0.30-0.66). Conclusions: Probiotics supplementation is effective in increasing the eradication rate during standard triple therapy for H. pylori eradication. Furthermore, probiotics show a positive impact on H. pylori therapy-related side-effects.
出处 《胃肠病学》 2007年第11期662-666,共5页 Chinese Journal of Gastroenterology
关键词 螺杆菌 幽门 Meta分析 有益菌种 根除率 不良反应 Helicobacter pylori Meta-Analysis Probiotics Eradication Rate Side Effects
  • 相关文献

参考文献18

  • 1Go MF. Review article: natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther, 2002, 16 Suppl 1: 3-15.
  • 2Valeur N, Engel P, Carbajal N, et al. Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract. Appl Environ Microbiol, 2004, 70 (2): 1176-1181.
  • 3Armuzzi A, Cremonini F, Ojetti V, et al. Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study. Digestion, 2001, 63 (1): 1-7.
  • 4Sykora J, Valeckov;i K, Amlerov;i J, et al. Effects of a specially designed fermented milk product containing probiotic Lactobacillus casei DN-114 001 and the eradication of H. pylori in children: a prospective randomized double-blind study. J Clin Gastroenterol, 2005, 39 (8): 692-698.
  • 5Sheu BS, Wu JJ, Lo CY, et al. Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther, 2002, 16 (9): 1669-1675.
  • 6Canducci F, Armuzzi A, Cremonini F, et al. A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment Pharmacol Ther, 2000, 14 (12): 1625- 1629.
  • 7Armuzzi A, Cremonini F, Bartolozzi F, et al. The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther, 2001, 15 (2):163-169.
  • 8Cremonini F, Di Caro S, Covino M, et al. Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am J Gastroenterol, 2002, 97 (11): 2744-2749.
  • 9Nista EC, Candelli M, Cremonini F, et al. Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. Aliment Pharmacol Ther, 2004, 20 (10): 1181-1188.
  • 10郭继兵,杨蒲芳,汪明涛,陆国义.酪酸菌在幽门螺杆菌治疗中的应用[J].中华腹部疾病杂志,2004,4(3):163-165. 被引量:4

二级参考文献9

  • 1Malfertheiner P,Megraud F,O'Morain C,Hungin AP,Jones R,Axon A,Graham DY,Tytgat G, European Helicobacter Pylori Study Group (EHPSG).Current concepts in the management of Helicobacter pylori infection --the Maastricht 2-2000 Consensus Report.Aliment Pharmacol Ther,2002,16:167~180.
  • 2Megraud F.Adjuvant therapy for Helicobacter pylori eradication:role of lansoprazole shown in vitro.J Clin Gastroenterol,1995,20 (Suppl 1):S24~S27.
  • 3Fujiyama K,Fujioka T,Kodama R,Nasu M.Effect of E3810,a novel proton pump inhibitor against Helicobacter pylori.Am J Gastroenterol,1994,89:1371.
  • 4Hirai M,Azuma T,Ito S,Kato T,Kohli Y.A proton pump inhibitor,E3810,has antibacterial activity through binding to Helicobacter pylori.J Gastroenterol,1995,30:461~464.
  • 5Miwa H,Ohkura R,Murai T,Sato K,Nagahara A,Hirai S,Watanabe S,Sato N.Impact of rabeprazole,a new proton pump inhibitor,in triple therapy for Helicobacter pylori infection-comparison with omeprazole and lansoprazole.Aliment Pharmacol Ther,1999,13:741~746.
  • 6Buzas GM,Jozan J.Eradication of Helicobacter pylori infection in Europe:a meta-analysis based on congress abstracts,1997-2002.Orv Hetil,2004,145:2035~2041.
  • 7Goodwin CS,Marshall BJ,Blincow ED,Wilson DH,Blackbourn S,Phillips M.Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate:clinical and in vitro studies.J Clin Pathol,1988,41:207~210.
  • 8Lam SK,Talley NJ.Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection.J Gastroenterol Hepatol,1998,13:1~12.
  • 9Gisbert JP,Calvet X,Gomollon F,Sainz R.Treatment for the eradication of Helicobacter pylori.Recommendations of the Spanish Consensus Conference Med Clin (Barc),2000,114:185~195.

共引文献16

同被引文献298

引证文献32

二级引证文献301

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部